Skip to content

Connecting business. Building understanding. Advancing peace.

UAE Investors Reallocate Capital to Chinese Healthcare and High-Dividend Equities

UAE-based asset managers are shifting investment into Chinese healthcare and high-dividend stocks following global AI equity volatility. Portfolio managers pointed to lower valuations and higher dividend yields compared with Western peers. Analysts noted that Gulf investors must manage currency risks due to the dirham's US dollar peg.

Illustration: A modern financial trading desk with computer monitors displaying financial charts, stock market data, and biopharmaceutical performance
Illustration

UAE-based asset managers are reallocating capital into Chinese healthcare and high-dividend assets amid volatility and valuation pullbacks in global artificial intelligence equities, Gulf News reported.

Portfolio managers noted that non-technology Chinese equities currently present attractive long-term growth prospects, lower valuation multiples, and higher dividend yields compared to Western peers. Specific holdings in healthcare and biopharma, including BeOne Medicines and Wuxi Biologics, were cited for delivering double-digit gains.

Market analysts emphasized that Gulf investors must carefully monitor cross-currency exposure because the UAE dirham remains pegged to the US dollar. The shift reflects broader diversification by Middle Eastern private capital across emerging Chinese industrial sectors.

Sources

The UECN Brief

Policy updates, China–UAE business news and industry insights, delivered to your inbox.

Language
Subscriptions

Double opt-in: we send a confirmation link. Unsubscribe at any time. Privacy